| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2990.1995.TB01022.X |
| P698 | PubMed publication ID | 7770118 |
| P2093 | author name string | Schapira AH | |
| P2860 | cites work | Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis | Q22242250 |
| A large kindred with autosomal dominant Parkinson's disease | Q28237850 | ||
| Ageing and Parkinson's disease: substantia nigra regional selectivity | Q29615835 | ||
| Alpha-tocopherol levels in brain are not altered in Parkinson's disease | Q33194048 | ||
| Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease | Q33220863 | ||
| Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect | Q33785020 | ||
| Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease | Q33789328 | ||
| The free radical hypothesis in idiopathic parkinsonism: evidence against it | Q35626740 | ||
| The oxidant stress hypothesis in Parkinson's disease: evidence supporting it | Q35626743 | ||
| Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group | Q35753957 | ||
| Complex I, iron, and ferritin in Parkinson's disease substantia nigra | Q36730657 | ||
| Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity | Q37683630 | ||
| Twin studies and the genetics of Parkinson's disease--a reappraisal | Q38124122 | ||
| NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH–ubiquinone reductase preparation | Q39273179 | ||
| Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal | Q40758643 | ||
| The possible role of iron in the etiopathology of Parkinson's disease | Q40868666 | ||
| Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease | Q41346993 | ||
| Rate of cell death in parkinsonism indicates active neuropathological process | Q41417978 | ||
| Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line | Q41544515 | ||
| Parkinson's disease: a disorder due to nigral glutathione deficiency? | Q41628096 | ||
| Neurotoxicity of levodopa on catecholamine-rich neurons | Q41646305 | ||
| Mitochondrial complex I deficiency in Parkinson's disease | Q41821730 | ||
| Decreased ferritin levels in brain in Parkinson's disease | Q42000755 | ||
| Alteration of inner-membrane components and damage to electron-transfer activities of bovine heart submitochondrial particles induced by NADPH-dependent lipid peroxidation | Q42168031 | ||
| Brain Peroxidase and Catalase in Parkinson Disease | Q44295221 | ||
| Sequential damage in mitochondrial complexes by peroxidative stress | Q44438376 | ||
| Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease | Q44808814 | ||
| Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations | Q45302799 | ||
| Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. | Q46015264 | ||
| Increased nigral iron content in postmortem parkinsonian brain | Q48182830 | ||
| Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. | Q48310314 | ||
| Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine | Q48316653 | ||
| Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients | Q48331251 | ||
| Glutathione peroxidase activity in Parkinson's disease brain | Q48462475 | ||
| Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine | Q48477579 | ||
| Quantitation of a mitochondrial DNA deletion in Parkinson's disease | Q48507765 | ||
| Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP | Q48590320 | ||
| Nigrostriatal Dopaminergic Neurons Remain Undamaged in Rats Given High Doses of l-DOPA and Carbidopa Chronically | Q48619910 | ||
| Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains | Q48789036 | ||
| Respiratory activity of isolated rat brain mitochondria following in vitro exposure to oxygen radicals | Q48800877 | ||
| Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture | Q48929977 | ||
| When did Ray Kennedy's Parkinson's disease begin? | Q52392414 | ||
| Photolabelling of a mitochondrially encoded subunit of NADH dehydrogenase with [3H]dihydrorotenone | Q52461227 | ||
| P433 | issue | 1 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 3-9 | |
| P577 | publication date | 1995-02-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
| P1476 | title | Oxidative stress in Parkinson's disease | |
| P478 | volume | 21 |
| Q40838697 | A biologically motivated partitioning of mortality |
| Q73661245 | Age-related changes in reactive oxygen species production in rat brain homogenates |
| Q42449719 | Aluminum potentiates glutamate-induced calcium accumulation and iron-induced oxygen free radical formation in primary neuronal cultures |
| Q28084254 | Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View |
| Q48483070 | Asymmetry of sympathetic activity in a rat model of Parkinson’s disease induced by 6-hydroxydopamine: haemodynamic, electrocardiographic and biochemical changes |
| Q83262328 | Challenges to the development of disease‐modifying therapies in Parkinson’s disease |
| Q48482071 | Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice |
| Q46851841 | Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system |
| Q41740100 | Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome? |
| Q35040174 | Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases. |
| Q43639267 | Effect of antioxidants on L-glutamate and N-methyl-4-phenylpyridinium ion induced-neurotoxicity in PC12 cells |
| Q31966978 | Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease. |
| Q42540598 | Expanded CTG repeats in myotonin protein kinase increase susceptibility to oxidative stress |
| Q28475323 | Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans |
| Q67212474 | Genes and parkinsonism. |
| Q41010065 | Genetic analysis of ageing: role of oxidative damage and environmental stresses. |
| Q34747340 | Human complex I defects in neurodegenerative diseases |
| Q38663090 | Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets. |
| Q34057625 | In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders? |
| Q44722680 | Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress |
| Q38085166 | Lipophilic fluorescent products of free radicals |
| Q48522703 | Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease. |
| Q48810698 | Mesencephalic neuron death induced by congeners of nitrogen monoxide is prevented by the lazaroid U-83836E. |
| Q38762971 | MiR-144-3p and Its Target Gene β-Amyloid Precursor Protein Regulate 1-Methyl-4-Phenyl-1,2-3,6-Tetrahydropyridine-Induced Mitochondrial Dysfunction |
| Q37037953 | Mitochondria in the aetiology and pathogenesis of Parkinson's disease |
| Q37891820 | Mitochondrial Contribution to Parkinson's Disease Pathogenesis |
| Q48844431 | Mitochondrial DNA polymorphism in substantia nigra |
| Q33580327 | Mitochondrial matters of the brain: the role in Huntington's disease |
| Q37954223 | Mitochondrial pathology in Parkinson's disease |
| Q37963572 | Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects |
| Q73101267 | Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurons and PC12 cells |
| Q41718471 | Neuropathology of Movement Disorders |
| Q40676919 | Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic lateral sclerosis mutations |
| Q33545307 | Neuroprotective therapies. |
| Q44865152 | Neurotoxicity of methamphetamine and methylenedioxymethamphetamine |
| Q64948819 | Parkinson's disease, amyotrophic lateral sclerosis and spinal muscular atrophy are caused by an unstable (CAG)n trinucleotide repeat microsatellite |
| Q74363334 | Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress |
| Q42727582 | Protection of dichlorvos induced oxidative stress and nigrostriatal neuronal death by chronic Coenzyme Q10 pretreatment |
| Q41846352 | Redistribution of glucose-6-phosphate dehydrogenase in response to cerebral ischemia in rat brain |
| Q29618019 | The Free Radical Theory of Aging Matures |
| Q35061204 | The combined transduction of copper, zinc-superoxide dismutase and catalase mediated by cell-penetrating peptide, PEP-1, to protect myocardium from ischemia-reperfusion injury |
| Q41011950 | Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids |
| Q73851259 | Xenobiotic-mediated production of superoxide by primary cultures of rat cerebral endothelial cells, astrocytes, and neurones |
Search more.